Eli Lilly sues six companies over illegal sale of experimental obesity drug
LLY Lilly(Eli) & Co
$1215.02 -1.37%
View chart & analysis → - 1Eli Lilly (LLY) has sued six U.S. companies over alleged illegal black-market sales of its experimental obesity drug retatrutide.
- 2The defendants include compounding pharmacies, medical spas, and online sellers; the drug is in Phase 3 trials and has not been approved for human use.
- 3In June, the FDA stated that consumer sales of unapproved retatrutide and other GLP-1 products are illegal, and Lilly has reported more than 200 entities to authorities.
This 3-line summary is compiled from the report below.
Reuters +2 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다